Fundraising Fox

Maiabiotech

Chicago, US · 1 known investors

maiabiotech.com ↗

Maia Biotech is a clinical-stage biotechnology company developing pipeline therapeutic products that are under clinical investigation.

Biotechin /maiabiotech@maiabiotech

Founders & leadership

VV
Vlad VitocExecutive Officer, Director
JH
Jeffrey HimmelreichHead of Finance
SG
Sergei GryaznovChief Scientific Officer
JC
Jeffrey C HimmelreichHead of Finance
SM
Steven M ChaoukiDirector
NY
Ngar Yee LouieDirector
CL
Cristian LuputDirector
JT
Jean-Manasse TheageneDirector
RG
Ramiro GuerreroDirector
SC
Steven ChaoukiDirector
SS
Stan SmithDirector
LN
Louie Ngar YeeDirector

Investors · 1

Checkmate Capital Group LLCPasadena

Reported raises · per SEC filings

Form D private placements
▶$1.5MraisedJan 2026 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sergei GryaznovExecutive Officer
  • Jean-Manasse TheageneDirector
  • Ramiro GuerreroDirector
  • Stan SmithDirector
  • Cristian LuputDirector
  • Vlad VitocExecutive Officer, Director
  • Jeffrey HimmelreichExecutive Officer, Director
  • Steven ChaoukiDirector
  • Louie Ngar YeeDirector
Offering amount
$2M
Amount sold
$1.5M
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedOct 2025 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Louie Ngar YeeDirector
  • Steven ChaoukiDirector
  • Stan SmithDirector
  • Sergei GryaznovExecutive Officer
  • Jeffrey HimmelreichExecutive Officer
  • Vlad VitocExecutive Officer, Director
  • Ramiro GuerreroDirector
  • Jean-Manasse TheageneDirector
  • Cristian LuputDirector
Offering amount
$7M
Amount sold
$3M
First sale
Sep 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$695KraisedJun 2025 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ramiro GuerreroDirector
  • Jean-Manasse TheageneDirector
  • Louie Ngar YeeDirector
  • Vlad VitocExecutive Officer, Director
  • Cristian LuputDirector
  • Jeffrey HimmelreichExecutive Officer
  • Steven ChaoukiDirector
  • Stan SmithDirector
  • Sergei GryaznovExecutive Officer
Offering amount
$8M
Amount sold
$695K
First sale
May 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedMar 2025 · 43 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cristian LuputDirector
  • Jeffrey HimmelreichExecutive Officer
  • Stan SmithDirector
  • Vlad VitocExecutive Officer, Director
  • Ramiro GuerreroDirector
  • Steven ChaoukiDirector
  • Louie Ngar YeeDirector
  • Sergei GryaznovExecutive Officer
  • Jean-Manasse TheageneDirector
Offering amount
$5.9M
Amount sold
$4.1M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedNov 2024 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cristian LuputDirector
  • Jean-Manasse TheageneDirector
  • Jeffrey HimmelreichExecutive Officer
  • Ramiro GuerreroDirector
  • Steven ChaoukiDirector
  • Sergei GryaznovExecutive Officer
  • Vlad VitocExecutive Officer, Director
  • Stan SmithDirector
  • Louie Ngar YeeDirector
Offering amount
$15.5M
Amount sold
$2.4M
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.9MraisedMar 2024 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey HimmelreichExecutive Officer
  • Stan V. SmithDirector
  • Cristian LuputDirector
  • Steven ChaoukiDirector
  • Sergei GryaznovExecutive Officer
  • Ngar Yee LouieDirector
  • Ramiro GuerreroDirector
  • Vlad VitocExecutive Officer, Director
  • Jean-Manasse TheageneDirector
Offering amount
$5.7M
Amount sold
$2.9M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.9MraisedNov 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cristian LuputDirector
  • Stan SmithDirector
  • Vlad VitocExecutive Officer, Director
  • Jeffrey C HimmelreichExecutive Officer
  • Ramiro GuerreroDirector
  • Sergei GryaznovExecutive Officer
  • Steven M ChaoukiDirector
  • Ngar Yee LouieDirector
  • Jean-Manasse TheageneDirector
Offering amount
$4.9M
Amount sold
$4.9M
Sales commissions
$280K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.